The Dow Jones closed slightly higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Wedbush initiated coverage on shares of Design Therapeutics (NASDAQ:DSGN – Get Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage set an “outperform” rating on the stock. A number of other analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Design Therapeutics from a […]
Design Therapeutics, Inc. (NASDAQ:DSGN – Get Rating) saw a large growth in short interest in April. As of April 30th, there was short interest totalling 4,060,000 shares, a growth of 37.2% from the April 15th total of 2,960,000 shares. Currently, 13.1% of the shares of the company are short sold. Based on an average trading […]
Shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $16.93, but opened at $16.28. Design Therapeutics shares last traded at $16.09, with a volume of 481 shares traded. Separately, The Goldman Sachs Group began coverage on shares of Design Therapeutics […]
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.